These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 229552)

  • 1. Killing of fibroblasts by dexamethasone or dibutyryl adenosine 3',5'-monophosphate is not a valid test for cystic fibrosis.
    Kurz JB; Perkins JP; Buchwald M
    Science; 1979 Dec; 206(4424):1317-9. PubMed ID: 229552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter to the editor: differential killing of normal and cystic fibrosis fibroblasts by dexamethasone.
    Epstein J; Breslow JL
    Pediatr Res; 1980 Aug; 14(8):964. PubMed ID: 7422400
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased dexamethasone resistance of cystic fibrosis fibroblasts.
    Epstein J; Breslow JL; Davidson RL
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5642-6. PubMed ID: 271991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropic drug resistance in cystic fibrosis fibroblasts: increased resistance to cyclic AMP.
    Epstein J; Breslow JL; Fitzsimmons MJ; Vayo MM
    Somatic Cell Genet; 1978 Jul; 4(4):451-64. PubMed ID: 210526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cAMP dependent chloride conductance is not different in cystic fibrosis fibroblasts.
    Squassoni E; Cabrini G; Berton G
    Life Sci; 1990; 46(18):1265-70. PubMed ID: 2161064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulatory effects of dibutyryl cyclic adenosine monophosphate on cytokine production by keratinocytes and fibroblasts.
    Zhou LJ; Ono I
    Br J Dermatol; 2000 Sep; 143(3):506-12. PubMed ID: 10971321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis and normal fibroblasts have identical glucocorticoid receptor profiles and induced protein responses.
    Khalid BA; Gyorki S; Warne GL; Funder JW
    Clin Endocrinol (Oxf); 1983 Apr; 18(4):407-15. PubMed ID: 6872270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone-resistant cystic fibrosis fibroblasts show cross-resistance to sex steroids.
    Breslow JL; Epstein J; Fontaine JH
    Cell; 1978 Apr; 13(4):663-9. PubMed ID: 657271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased resistance of cystic fibrosis fibroblasts to ouabain toxicity.
    Epstein J; Breslow JL
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1676-9. PubMed ID: 266207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclic AMP on chromatin-bound protein kinases in WI-38 fibroblasts stimulated to proliferate.
    Bombik BM; Baserga R
    Biochim Biophys Acta; 1976 Sep; 442(3):343-57. PubMed ID: 183819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential killing of normal and cystic fibrosis fibroblasts by dexamethasone.
    Breslow JL; Epstein J
    Science; 1980 Feb; 207(4434):1007-8. PubMed ID: 7352296
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth induction in cystic fibrosis fibroblasts with low dexamethasone concentrations. Experience with application to genotyping.
    Daniel A; Stewart L; Lam-Po-Tang PR; Beveridge J; Morton J
    Hum Genet; 1981; 57(1):96-8. PubMed ID: 7262876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth arrest and morphological change of human breast cancer cells by dibutyryl cyclic AMP and L-arginine.
    Cho-Chung YS; Clair T; Bodwin JS; Berghoffer B
    Science; 1981 Oct; 214(4516):77-9. PubMed ID: 6269181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced dexamethasone resistance in cystic fibrosis cells: potential use for heterozygote detection and prenatal diagnosis.
    Breslow JL; Epstein J; Fontaine JH; Forbes GB
    Science; 1978 Jul; 201(4351):180-2. PubMed ID: 663650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis fibroblasts respond normally to isoproterenol.
    Kurz JB; Perkins JP
    Pediatr Res; 1981 Oct; 15(10):1328-33. PubMed ID: 6170925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis patients' B-lymphocyte response is resistant to the in vitro enhancing effect of corticosteroids.
    Emilie D; Crevon MC; Chicheportiche R; Auffredou MT; Barot-Ciorbaru R; Lenoir G; Dayer JM; Galanaud P
    Eur J Clin Invest; 1990 Dec; 20(6):620-6. PubMed ID: 1964124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological differentiation of cultured mouse glioblastoma cells induced by dibutyryl cyclic adenosine monophosphate.
    Sato S; Sugimura T; Yoda K; Fujimura S
    Cancer Res; 1975 Sep; 35(9):2494-9. PubMed ID: 167961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal levels of 3':5'-cyclic AMP in isoproterenol-stimulated fibroblasts from patients with cystic fibrosis.
    Buchwald M
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2899-903. PubMed ID: 183214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin production by neuroblastoma, glioma and fibroblast cell lines; stimulation by N6,02'-dibutyryl adenosine 3':5'-cyclic monophosphate.
    Hamprecht B; Jaffee BM; Philpott GW
    FEBS Lett; 1973 Oct; 36(2):193-8. PubMed ID: 4356788
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway.
    Matsunaga T; Gohda E; Takebe T; Wu YL; Iwao M; Kataoka H; Yamamoto I
    Exp Cell Res; 1994 Feb; 210(2):326-35. PubMed ID: 7507855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.